Pro-life experts gathered for a telephone press conference just hours before the Food and Drug Administration (FDA) announced its approval of Ella, the abortion drug being marketed as a morning-after pill. While the decision had not been released, panelists were confident that the FDA would decide to allow Ella, ulipristal, on the market. CWA President Wendy Wright participated in the teleconference hosted by the Family Research Council. Click here to find talking points on Ella.
J.P. Duffy, Vice President for Communications, Family Research Council –
Wendy Wright, President of Concerned Women for America –
Kristen Hawkins, Executive Director of Students for Life of America –
David Bereit, National Director, 40 Days for Life –
Jeanne Monahan, Director of the Center for Human Dignity, Family Research Council –